Injectable Drug Delivery Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026

1. Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2. Executive Summary

• 2.1 Report Guide
• 2.2 Methodology
• 2.3 Market Segmentation
• 2.4 Injectable Drug Delivery Market- Key Findings, 2020

3. Strategic Imperatives on Global Injectable Drug Delivery Market

• 3.1 COVID-19 Impact Analysis
• 3.2 Market Trends- Across Types, Applications, End User Types, Countries
• 3.3 Insights into Main Market Categories
• 3.4 Market Drivers and Restraints
• 3.5 Growth Opportunities Critical for Future Success
• 3.6 Key Injectable Drug Delivery Companies

4. Global Injectable Drug Delivery Market Value Outlook to 2026 Outlook by Type

• 4.1 Formulation
  • 4.1.1 Conventional Drug Delivery
    • 4.1.1.1 Suspensions
    • 4.1.1.2 Solutions
    • 4.1.1.3 Lyophilized Formulations
    • 4.1.1.4 Emulsions
  • 4.1.2 Novel Drug Delivery
    • 4.1.2.1 Long Acting Injection Formulation
    • 4.1.2.2 Microparticles
    • 4.1.2.3 Colloidal Dispersions
  • 4.1.3 Others
• 4.2 Devices
  • 4.2.1 Self-Injection Devices
    • 4.2.1.1 Needle-Free Injectors (NFI)
    • 4.2.1.2 Wearable Injectors
    • 4.2.1.3 Pen Injectors
    • 4.2.1.4 Auto-Injectors
    • 4.2.1.5 Others
  • 4.2.2 Conventional Injection Devices
    • 4.2.2.1 Prefilled Syringes
    • 4.2.2.2 Fillable Syringes
    • 4.2.2.3 Others

  5. Global Injectable Drug Delivery Market Value Outlook to 2026 Outlook by Application

  • 5.1 Autoimmune Diseases
  • 5.2 Oncology Disorders
  • 5.3 Hormonal Disorders
  • 5.4 Orphan Diseases
  • 5.5 Others

  6. Global Injectable Drug Delivery Market Value Outlook to 2026 Outlook by End-User

  • 6.1 Home Care
  • 6.2 Hospital
  • 6.3 Ambulatory Care
  • 6.4 Physician Offices or Clinics
  • 6.5 Others

  7 Asia Pacific Injectable Drug Delivery Market Value Outlook to 2026

  • 7.1 Leading Injectable Drug Delivery Types contributing to Asia Pacific market
  • 7.2 Top Applications contributing to Asia Pacific Injectable Drug Delivery
  • 7.3 Top countries contributing to Asia Pacific Injectable Drug Delivery

  8 Europe Injectable Drug Delivery Market Value Outlook to 2026

  • 8.1 Leading Injectable Drug Delivery Types contributing to Europe market
  • 8.2 Top Applications contributing to Europe Injectable Drug Delivery
  • 8.3 Top countries contributing to Europe Injectable Drug Delivery

  9 North America Injectable Drug Delivery Market Value Outlook to 2026

  • 9.1 Leading Injectable Drug Delivery Types contributing to North America market
  • 9.2 Top Applications contributing to North America Injectable Drug Delivery
  • 9.3 Top countries contributing to North America Injectable Drug Delivery

  10 South and Central America Injectable Drug Delivery Market Value Outlook to 2026

  • 10.1 Leading Injectable Drug Delivery Types contributing to South and Central America market
  • 10.2 Top Applications contributing to South and Central America Injectable Drug Delivery
  • 10.3 Top countries contributing to South and Central America Injectable Drug Delivery

  11 Middle East Africa Injectable Drug Delivery Market Value Outlook to 2026

  • 11.1 Leading Injectable Drug Delivery Types contributing to Middle East Africa market
  • 11.2 Top Applications contributing to Middle East Africa Injectable Drug Delivery
  • 11.3 Top countries contributing to Middle East Africa Injectable Drug Delivery

  12 Business Profiles of Leading Companies

  • 12.1 Business Description, SWOT and Financial Analysis of Companies in Injectable Drug Delivery market
  • 12.2 ALKERMES PUBLIC LIMITED COMPANY
  • 12.3 Antares Pharma
  • 12.4 Baxter International, Inc.
  • 12.5 Becton, Dickinson and Company
  • 12.6 Elcam Medical
  • 12.7 ELI Lilly and Company
  • 12.8 Gerresheimer AG
  • 12.9 Injex Pharma GmbH
  • 12.10 NOVO NORDISK
  • 12.11 Pfizer, Inc.

  13 Recent Industry Developments

  14 Appendix

  • 14.1 OGAnalysis Expertise
  • 14.2 Sources and Methodology